| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Brazil | 2 | |
| #5 | Taiwan | 2 | |
| #6 | United States | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 | |
| #8 | China | 1 | |
| #9 | Hong Kong | 1 | |
| #10 | Republic of Korea | 1 | |
| #11 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mao Long | 18 |
| #2 | Wu Jian | 16 |
| #3 | Liu Jia | 16 |
| #4 | Hua Yuning | 14 |
| #5 | Wang Xiaobo | 14 |
| #6 | Weng Bojie | 14 |
| #7 | Dai Kongen | 14 |
| #8 | Mo Xiaopeng | 14 |
| #9 | Xu Xiao | 14 |
| #10 | Bao Yimei | 14 |
| Publication | Filing date | Title |
|---|---|---|
| CA3109085A1 | Process for manufacture of (s)-n-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy) phenyl)acrylamide, and formulations thereof | |
| CA3059072A1 | Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same | |
| AU2016334141A1 | Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same |